Portuguese biotech company Immunethep has convinced the Bill & Melinda Gates Foundation to hand out a grant to test its antibody against the bacterial extracellular virulence factor GAPDH.
https://european-biotechnology.com/wp-content/uploads/2024/04/2017_10_25_immunethep.jpg6291120Thomas Gabrielczyk/wp-content/uploads/2024/07/EBM_quer_Logo_2022_400px_wihte.pngThomas Gabrielczyk2017-10-25 12:04:012017-10-25 12:04:01Immunethep receives grant from Gates Foundation